Patrick Elwood
Hematology & Oncology · Columbus, OHNPI 1083672760
Payments from drug & device makers
Across 137 payments — averaging $37.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rigel Pharmaceuticals, Inc.$3K
- AstraZeneca$384
- Eisai Inc.$358
- Seagen Inc.$162
- Bristol Myers Squibb$101
- Amgen$98
- plus $1K from 37 others
What the payments were for
- Speaking & faculty fees$2,50049%
- Food & beverage$2,57250%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,112 in reported general payments places this provider in the 45th percentile of 450 hematology & oncology providers in Ohio.
Other hematology & oncology in Columbus
- Anne NoonanColumbus$1.5M
- Taral PatelColumbus$921K
- Tarek ChidiacColumbus$828K
- Kathleen KerriganColumbus$817K
- Jeanna KnobleColumbus$814K
- Afshin DowlatiCleveland$25.1M
- Brian HillCleveland$11.6M
- Trisha Wise-DraperCincinnati$9.8M
- Davendra SohalCincinnati$8.6M
- Christopher HoimesCleveland$7.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.